You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-TIMP3 antibody (ab2169)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-TIMP3 antibody
See all TIMP3 products (11) ...

Description

Rabbit polyclonal to TIMP3

Specificity

This antibody reacts with a 23 kDa protein, known as TIMP 3.

Tested applications

ICC/IF, IHC-P, IHC-Frmore details

Cross reactivity

Reacts with

Rabbit, Human, Baboon

Immunogen

Synthetic peptide from the C-terminus region of the human TIMP-3.

Positive control

Breast carcinoma

Properties

Form

Liquid

Storage instructions

Store at +4°C.

Storage buffer

Preservative: 0.05% Sodium Azide
Constituents: 1% BSA

Concentration

Concentration information loading...

Purity

Protein A purified

Clonality

Polyclonal

Isotype

IgG

Applications

Show applications key

Our Abpromise guarantee covers the use of ab2169 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

ICC/IF: Use at an assay dependent dilution (PMID 19324423).
IHC-P: Use at an assay dependent concentration.
IHC-Fr: Use at an assay dependent concentration.


Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Complexes with metalloproteinases (such as collagenases) and irreversibly inactivates them by binding to their catalytic zinc cofactor. May form part of a tissue-specific acute response to remodeling stimuli. Known to act on MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, MMP-13, MMP-14 and MMP-15.

Involvement in disease

Defects in TIMP3 are the cause of Sorsby fundus dystrophy (SFD) [MIM:136900]. SFD is a rare autosomal dominant macular disorder with an age of onset in the fourth decade. It is characterized by loss of central vision from subretinal neovascularization and atrophy of the ocular tissues. Generally, macular disciform degeneration develops in the patients eye within 6 months to 6 years.

Sequence similarities

Belongs to the protease inhibitor I35 (TIMP) family.
Contains 1 NTR domain.

Cellular localization

Secreted > extracellular space > extracellular matrix.

Target information above from: UniProt accessionP35625 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • HSMRK222 antibody
  • K222 antibody
  • K222TA2 antibody
  • Metalloproteinase inhibitor 3 antibody
  • MIG 5 protein antibody
  • MIG5 protein antibody
  • Protein MIG 5 antibody
  • Protein MIG-5 antibody
  • SFD antibody
  • Sorsby fundus dystrophy pseudoinflammatory antibody
  • TIMP 3 antibody
  • TIMP metallopeptidase inhibitor 3 antibody
  • TIMP-3 antibody
  • TIMP3 antibody
  • TIMP3_HUMAN antibody
  • Tissue Inhibitor of Metalloproteinase 3 antibody
  • Tissue inhibitor of metalloproteinases 3 antibody
  • Tissue inhibitor of metalloproteinases3 antibody
see all

References for Anti-TIMP3 antibody (ab2169)

This product has been referenced in:

  • Hurst LAet al. Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment. J Neuroimmunol 210:108-12 (2009). ICC/IF; Human.Read more (PubMed: 19324423) »

See 1 publication for this product

Publishing research using ab2169? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"